How Much Money Do You Get From Donating Bone Marrow?

In the United States and most countries worldwide, you receive no payment for donating bone marrow. The process is treated as a voluntary, altruistic act, and federal law has historically made it a felony to offer or accept money for bone marrow. Some legal and regulatory shifts in recent years have opened narrow exceptions for one specific collection method, but the practical reality for the vast majority of donors is that you walk away without a check. What you can get is reimbursement for out-of-pocket costs like travel and lost wages, and in some states, your employer is legally required to give you paid time off for the process.

Why Paying Donors Is Illegal

The National Organ Transplant Act of 1984 (NOTA) made it a federal crime to buy or sell human organs, punishable by up to five years in prison and a $50,000 fine. Bone marrow was explicitly listed among the organs covered by the ban.¹ At the time NOTA was written, the only way to collect bone marrow stem cells was to insert needles directly into the donor’s pelvic bones and aspirate the marrow out, a surgical procedure done under general anesthesia. Congress treated bone marrow the same way it treated kidneys and livers: as a body part that should never be commodified.

This legal framework meant that registries like the National Marrow Donor Program (now called Be The Match) built their entire model around volunteer donors. The World Marrow Donor Association reinforced this approach internationally, arguing that paying donors raises ethical problems including the risk of coercion, the potential to exploit low-income people, and the possibility that paid donors might conceal health information that would disqualify them.² The concern is not abstract: a donor who lies about a medical condition to collect payment could endanger the patient receiving the transplant.

The Legal Gray Area Around Peripheral Blood Stem Cells

Here is where things get complicated. Since the 1990s, the medical field has increasingly shifted toward a second collection method called peripheral blood stem cell (PBSC) donation. Instead of surgically extracting marrow from your bones, doctors give you injections of a drug called filgrastim for several days beforehand, which pushes stem cells out of your bone marrow and into your bloodstream. Then you sit in a chair while a machine draws blood from one arm, filters out the stem cells, and returns the rest of your blood through the other arm. The whole collection takes a few hours and requires no anesthesia or operating room.

In 2011, the Ninth Circuit Court of Appeals ruled in Flynn v. Holder that PBSC donation is fundamentally different from traditional bone marrow aspiration. The court said that because PBSC collection works more like a blood draw than a surgical harvest, it should not fall under NOTA’s ban on organ sales.³ Then in August 2017, the U.S. Department of Health and Human Services issued guidance that effectively made compensation legal for bone marrow collected through this method.⁴

In theory, this means someone could legally pay you for PBSC donation. In practice, almost no one does. The major registries continue to operate on a volunteer model, and the WMDA’s ethical guidelines still oppose payment. A few small pilot programs have experimented with offering non-cash incentives like scholarships, housing vouchers, or charitable donations in the donor’s name, but these remain fringe efforts. If you sign up with Be The Match or a similar registry today, you should expect to donate for free.

Financial Support You Actually Receive

While you won’t be paid for your cells, registries do cover the direct costs of donating so the process doesn’t leave you out of pocket. Be The Match, for example, reimburses donors for travel to and from the collection center, hotel stays if you need to travel overnight, meals during the donation process, and some child-care or dependent-care expenses. Medical costs associated with the donation itself, including pre-donation physicals, the collection procedure, and follow-up care, are covered by the patient’s insurance or the registry. You should never receive a medical bill for donating.

Many U.S. states have gone further by passing legislation that provides leave to bone marrow donors and tax benefits for both donors and their employers.⁵ The details vary by state, but common provisions include guaranteed paid or unpaid leave from work (often five to seven days for bone marrow), tax deductions for unreimbursed expenses, and tax credits for employers who provide paid leave to donating employees. Research suggests these leave laws actually increase the number of bone marrow donations, which makes sense: the laws work for moderately invasive procedures where lost wages are a real barrier but the physical burden is manageable.

For federal employees, there is a separate policy allowing up to seven days of paid leave for bone marrow donation. Some large private employers offer similar benefits voluntarily. If you’re considering becoming a donor, it’s worth checking both your state’s laws and your employer’s policies before assuming you’ll lose income.

What Donation Actually Costs You Physically

Understanding the real “cost” of donation means understanding what your body goes through. The two collection methods have different recovery profiles, and which one you undergo depends on what the patient’s doctor recommends.

Traditional bone marrow aspiration involves a hospital stay (typically two days) and general or regional anesthesia. A large needle is inserted into the back of the pelvic bone to withdraw liquid marrow. PBSC donors, by contrast, spend zero days in the hospital for the collection itself, though they receive filgrastim injections at home or at a clinic for four to five days beforehand.⁶ In a large randomized study comparing the two methods, bone marrow donors had a median of six days of restricted activity afterward, while PBSC donors had about two days.

Neither method is risk-free. In the same study, roughly 57% of bone marrow donors and 65% of PBSC donors reported at least one adverse event, though most were mild to moderate and resolved on their own. For PBSC donors specifically, a large prospective trial of over 2,400 unrelated donors found that nearly all experienced bone pain from the filgrastim injections, about one in four had significant headaches or nausea, and about 6% experienced more serious short-term side effects.⁷ Complete recovery was universal in that study, and no late adverse events tied to the donation were identified.

The filgrastim drug used in PBSC mobilization carries a rare but real risk of splenic rupture. Case reports exist of otherwise healthy donors developing this complication during the mobilization period.⁸ Registries monitor for this by instructing donors to report sudden abdominal pain immediately. Long-term follow-up data from nearly 4,000 PBSC donors at a single center over 12 years showed no increased cancer risk attributable to the growth factor, though the researchers emphasized that continued monitoring remains important.⁹ A separate study comparing PBSC and bone marrow donors also found no evidence of increased cancer, autoimmune illness, or stroke risk among those who received the growth factor.¹⁰

Who Bears the Financial Burden and Why It Matters

Even with travel reimbursement and leave laws, donating bone marrow involves real financial friction. You might need to take time off work beyond what your employer or state guarantees. You might need child care that isn’t fully reimbursable. Self-employed donors lose income with no safety net. These costs are invisible in the system’s design because the model assumes donors are motivated purely by altruism and that removing the direct out-of-pocket expenses is enough.

Research into whether removing these financial barriers increases donations has produced a nuanced picture. State-level leave laws appear to boost bone marrow donation rates, and the effect grows stronger when the laws are more generous and when the population of potential beneficiaries is larger. But tax incentive provisions for organ donation showed no measurable impact on donation rates.⁵ The interpretation is that for a moderately burdensome procedure like bone marrow donation, protecting a person’s paycheck during recovery is enough to tip the scales. For more invasive procedures with longer recovery, the incentives may be too small to matter.

This creates an uncomfortable tension. Thousands of patients die each year waiting for a matched donor, and minority populations face particularly severe shortages because matching depends on shared genetic ancestry. Paying donors could, in theory, expand the pool. But the medical establishment worries that payment would attract donors who are less forthcoming about their health, reduce the quality of the donor pool, and create a system where wealthier countries drain stem cells from poorer ones. The World Marrow Donor Association has laid out these concerns explicitly, arguing that the risks to patient safety and equitable access outweigh the potential gains.²

How International Registries Handle Money

The volunteer model is not uniquely American. The World Marrow Donor Association sets international standards for unrelated donor registries, and those standards emphasize voluntarism across borders.¹¹ When a patient in one country needs stem cells from a donor in another, the financial and legal responsibilities are spelled out in advance: the patient’s transplant center or insurance typically pays the collection costs, shipping, and courier fees. The donor sees none of that money. Countries that participate in these exchanges follow the same core principle that the donor acts voluntarily and without compensation.

There are variations at the edges. Some countries allow small tokens of appreciation, like gift cards or time-off certificates, that fall below a threshold considered “compensation.” Others reimburse lost earnings more generously than the U.S. does. But nowhere in the world does a mainstream registry hand a bone marrow donor a payment in exchange for their cells. The consensus among transplant medicine professionals, even those who find the current system imperfect, is that the risks of a paid market outweigh the benefits.

Donor Demographics and Adverse Events

If you’re a woman considering PBSC donation, the evidence suggests your experience may differ from a male donor’s. In the large National Marrow Donor Program trial, female donors had higher rates of adverse events across multiple categories: they needed central line placement more often (about 17% versus 4% for men), experienced more apheresis-related complications, and reported more bone pain. Female and obese donors both showed higher rates of more significant side effects.⁷ None of this means donation is unsafe for women or heavier individuals. The side effects were still overwhelmingly short-lived. But it’s information worth having before you volunteer, especially since no one will be compensating you for the discomfort.

Long-term follow-up remains an active area of concern. A review of severe events after donation concluded that continuous, standardized follow-up is needed to better define which donors face the most risk and to track any intermediate or long-term consequences.¹² Most registries now follow donors for years after the procedure, tracking blood counts, general health, and any new diagnoses. In the 12-year single-center study of nearly 4,000 donors, the vast majority reported good or very good health throughout follow-up. Absolute white blood cell counts dipped slightly below baseline but stayed in the normal range.⁹

What Happens If You’re Asked to Donate a Second Time

One scenario donors rarely anticipate is being asked to donate again. If the patient’s initial transplant fails or relapses, the transplant center may contact you to ask for a second donation. Registries are clear that this is always voluntary, and you can decline without explanation. But the request can create emotional pressure that feels very different from the original sign-up, when the patient was an abstract concept. International standards address second and subsequent donations specifically, requiring registries to ensure that donors are fully informed and freely consenting each time.¹¹

Financially, the same rules apply: you won’t be paid, but your costs will be covered. The physical demands are similar to the first time. Some donors report that the second experience is easier because they know what to expect; others find the filgrastim side effects just as unpleasant. There is no evidence that donating twice increases your long-term health risks beyond what a single donation carries, though the data on repeat donors is thinner simply because fewer people go through it.